Phase II clinical trial - Recherches "plusieurs pathologies"
MOST Plus
Recherches "plusieurs pathologies"
Ouvert depuis le: 04.27.2024
Site: Paris
Public cible
Adulte
My Own Specific Treatment : A two-period, multicenter, randomized, open-label, phase II study evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with progressive locally-advanced or metastatic solid tumors
Description de l'essai
This trial evaluates the efficacy of 4 oral targeted therapies (everolimus, sorafenib, pazopanib, and nilotinib) in patients with any kind of cancer whose harbour the matching targets of these drugs.
Liens utiles
CHRISTOPHE LE TOURNEAU
Investigateur principal